2017 Press Releases

2017 | 2016 | 2015
Keyword Search
 
DateTitle 
11/21/17Depomed to Participate at the Annual Piper Jaffray Healthcare ConferencePrinter Friendly Version
11/07/17Depomed Announces Third Quarter 2017 Financial ResultsPrinter Friendly Version
11/07/17Depomed and Slán Medicinal Holdings Ltd Announce Strategic Asset TransactionsPrinter Friendly Version
10/31/17Depomed to Report Third Quarter 2017 Financial Results on Tuesday, November 7, 2017Printer Friendly Version
10/18/17Depomed Announces Appointment of Santosh J. Vetticaden, M.D., PH.D. as Senior Vice President, Chief Medical and Scientific OfficerPrinter Friendly Version
10/10/17Depomed Provides Product Supply Information Following Hurricane MariaPrinter Friendly Version
09/05/17Depomed to Present at the Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
08/28/17Depomed to Join the Collaborative for Effective Prescription Opioid Policies to Advance Strategies Aimed at Addressing the Abuse of OpioidsPrinter Friendly Version
08/07/17Depomed Announces Second Quarter 2017 Financial ResultsPrinter Friendly Version
07/31/17Depomed to Report Second Quarter 2017 Financial Results on Monday, August 7, 2017Printer Friendly Version
07/13/17Depomed Announces Intent to Effect a Debt RefinancingPrinter Friendly Version
05/22/17Depomed Announces Corporate Governance UpdatesPrinter Friendly Version
05/16/17Depomed to Present at the UBS Global Healthcare ConferencePrinter Friendly Version
05/09/17Depomed Announces First Quarter 2017 Financial Results and Strategic Initiatives Aimed at Driving Sustainable Long-Term Growth and Shareholder ValuePrinter Friendly Version
05/02/17Depomed to Report First Quarter 2017 Financial Results on Tuesday, May 9, 2017Printer Friendly Version
04/25/17Depomed Announces Appointment of Sharon D. Larkin as Senior Vice President, Human Resources and AdministrationPrinter Friendly Version
04/04/17Depomed Announces Prepayment of $100 Million of Secured Debt FacilityPrinter Friendly Version
03/28/17Depomed Announces Cooperation Agreement with Starboard Value LP Including CEO and Board ChangesPrinter Friendly Version
03/06/17Depomed to Present at Healthcare Conferences in MarchPrinter Friendly Version
02/21/17Depomed Reports Fourth Quarter and Full Year 2016 Financial ResultsPrinter Friendly Version
02/17/17Depomed to Report Fourth Quarter Fiscal Year 2016 Financial Results on Tuesday, February 21, 2017Printer Friendly Version
02/08/17Depomed to Present at Healthcare Conferences in FebruaryPrinter Friendly Version

DEPO (Common Stock)

Exchange
NASDAQ CM
Price
$6.18
Change (%)
 + 0.02 (0.32%)
Volume
837,242
Market Cap
$389,423,127

Data as of 11/21/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Powered By EDGAR Online, Inc.